Location: Palo Alto, CA
CIK: 0001892134 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $4.592B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MIRM | MIRUM PHARMACEUTICALS INC | 7,679,684 | $899M | 19.6% | — | — | COM | 604749101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 18,088,902 | $613M | 13.3% | — | — | ORDINARY SHARES | N62509109 |
| ERAS | ERASCA INC | 24,975,188 | $458M | 10.0% | — | — | COM | 29479A108 |
| MBX | MBX BIOSCIENCES INC | 6,652,013 | $367M | 8.0% | — | — | COM | 55287L101 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 9,874,511 | $259M | 5.6% | — | — | COM | 03969K108 |
| TRVI | TREVI THERAPEUTICS INC | 9,939,447 | $185M | 4.0% | — | — | COM | 89532M101 |
| KRYS | KRYSTAL BIOTECH INC | 481,307 | $179M | 3.9% | — | — | COM | 501147102 |
| MAZE | MAZE THERAPEUTICS INC | 5,032,915 | $150M | 3.3% | — | — | COM | 578784100 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 12,466,489 | $135M | 2.9% | — | — | COM | 71722W107 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 882,400 | $135M | 2.9% | — | — | COM | 697947109 |
| BBIO | BRIDGEBIO PHARMA INC | 1,548,139 | $115M | 2.5% | — | — | COM | 10806X102 |
| IRON | DISC MEDICINE INC | 1,354,852 | $99.09M | 2.2% | — | — | COM | 254604101 |
| CYTK | CYTOKINETICS INC | 1,159,879 | $98.81M | 2.2% | — | — | COM NEW | 23282W605 |
| DYN | DYNE THERAPEUTICS INC | 3,153,082 | $70.03M | 1.5% | — | — | COM | 26818M108 |
| ASND | ASCENDIS PHARMA A/S | 225,155 | $60.05M | 1.3% | — | — | SPONSORED ADR | 04351P101 |
| SVRA | SAVARA INC | 9,720,852 | $59.88M | 1.3% | — | — | COM | 805111101 |
| PBLS | PARABILIS MEDICINES INC | 1,920,805 | $52.57M | 1.1% | — | — | COM | 698955101 |
| AURA | AURA BIOSCIENCES INC | 7,100,000 | $50.41M | 1.1% | — | — | COM | 05153U107 |
| ACHV | ACHIEVE LIFE SCIENCE INC | 7,614,836 | $49.72M | 1.1% | — | — | COM | 004468500 |
| VOR | VOR BIOPHARMA INC | 2,543,939 | $46.83M | 1.0% | — | — | COM NEW | 929033207 |
| ALLO | ALLOGENE THERAPEUTICS INC | 22,446,668 | $46.69M | 1.0% | — | — | COM | 019770106 |
| TARS | TARSUS PHARMACEUTICALS INC | 728,644 | $45.86M | 1.0% | — | — | COM | 87650L103 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 4,009,240 | $40.09M | 0.9% | — | — | COM | 09058V103 |
| ALKS | ALKERMES PLC | 700,647 | $36.71M | 0.8% | — | — | SHS | G01767105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,438,198 | $36.39M | 0.8% | — | — | COM | 004225108 |
| ZLAB | ZAI LAB LTD | 1,902,320 | $36.14M | 0.8% | — | — | ADR | 98887Q104 |
| MNKD | MANNKIND CORP | 6,600,000 | $28.12M | 0.6% | — | — | COM NEW | 56400P706 |
| DSGN | DESIGN THERAPEUTICS INC | 1,809,854 | $26.19M | 0.6% | — | — | COM | 25056L103 |
| ACRS | ACLARIS THERAPEUTICS INC | 4,925,374 | $26.06M | 0.6% | — | — | COM | 00461U105 |
| STTK | SHATTUCK LABS INC | 3,750,000 | $26.02M | 0.6% | — | — | COM | 82024L103 |
| KLRA | KAILERA THERAPEUTICS INC | 1,100,000 | $24.23M | 0.5% | — | — | COMMON STOCK | 482931102 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 1,000,000 | $24.2M | 0.5% | — | — | COM | 61225M102 |
| LXEO | LEXEO THERAPEUTICS INC | 4,824,725 | $22.46M | 0.5% | — | — | COM | 52886X107 |
| RLAY | RELAY THERAPEUTICS INC | 1,015,693 | $19M | 0.4% | — | — | COM | 75943R102 |
| EOLS | EVOLUS INC | 2,630,665 | $18.26M | 0.4% | — | — | COM | 30052C107 |
| IMCR | IMMUNOCORE HLDGS PLC | 484,782 | $15.39M | 0.3% | — | — | ADS | 45258D105 |
| VALN | VALNEVA SE | 2,291,666 | $11.99M | 0.3% | — | — | SPONSORED ADS | 92025Y103 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 500,333 | $10.69M | 0.2% | — | — | *W EXP 99/99/999 | N62509117 |
| AUTL | AUTOLUS THERAPEUTICS LTD | 4,447,910 | $7.117M | 0.2% | — | — | SPON ADS | 05280R100 |
| XLO | XILIO THERAPEUTICS INC | 422,505 | $4.048M | 0.1% | — | — | COM | 98422T209 |
| IBIO | IBIO INC | 1,953,467 | $3.419M | 0.1% | — | — | COM NEW | 451033708 |